Affiliation: | 1INSERM U161, Laboratoire de Recherches de Neurophysiologie Pharmacologique, Paris, France 2Section de Pharmacologie et d'Immunologie, Laboratoire d'Etudes Radioimmunologiques, De´partement de Biologie, Commissariata`l'Energie Atomique Centre d'Etudes Nucle´aires/Saclay, Gif sur Yvette Cedex, France 3Universite´Pierre et Marie Curie, Paris, France |
Abstract: | Mice immunized against anti-substance P (anti-SP) monoclonal antibodies produced anti-SP anti-idiotypic antibodies (SPAb2). In a previous report. SPAb2 antibodies were found to have in vitro biological activity i.e. to behave either as agonists or as antagonists for substance P (SP) depending on the biological test. In this study, the involvement of SPAb2 in vivo biological activity has been tested. Because of the possible implication of SP in the generation and transmission of nociceptive information, we have tested the responsiveness of SPAb2 responding mice in behavioral nociceptive tests. SPAb2 mice showed very small behavioral variations in the hot plate test as compared with a control group of mice immunized against an unrelated monoclonal antibody. In the formalin test, however, SPAb2 mice displayed a significant increase in paw licking time, which was significantly correleted with SPAb2 serum concentration. These results are discussed in terms of the use of SPAb2 as pharmacological tools for studying the biological properties of SP receptors and more generally of auto anti-idiotypic antibodies in modulating behavior responses. |